Patents Assigned to AVANTI BIOSCIENCES, INC
  • Publication number: 20180000774
    Abstract: The present invention relates to methods of treating cognitive and behavioral impairment in Down syndrome and/or Alzheimer's disease patients, Alzheimer's disease, neurodegenerative disease, cancer, DYRK1A-mediated disorders and methods of modulating and inhibiting DYRK1-A comprising use of catechins.
    Type: Application
    Filed: June 27, 2017
    Publication date: January 4, 2018
    Applicant: AVANTI BIOSCIENCES, INC
    Inventor: GIAN LUCA ARALDI